ATLANTA -- The concept of using stents to seal off non-flow-limiting vulnerable plaques, before they have a chance to rupture, worked out in the first major trial testing this provocative idea.

This is a summary of a preprint research study written by authors from Chiba University, Japan, on Research Square, provided to you by Medscape. This study has not yet been peer reviewed. Visit ...

A new strategy for the management of atherosclerotic plaque as a source of major adverse cardiac events is needed with the focus shifting from the flow-limiting coronary artery luminal lesions to the ...

It is not an uncommon story–a fit man in his 40s or 50s arrives at his doctor’s office for his annual checkup and eventually leaves with a clean bill of health. Soon afterward he drops dead of a heart ...

University of Houston professor Ioannis Kakadiaris (right) and PhD student Sean O'Malley examine intravascular ultrasound data recorded in a coronary artery of a patient suffering from atherosclerosis ...